Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data. 

Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.

Ataraxis AI

The office focuses on advanced research and development in machine learning, oncology, and data partnerships.

169 Madison Ave

Jan Witowski MD

This department focuses on the diagnosis, treatment, and research of cancer and related conditions.

Oncology Department

This department oversees the strategic direction and management of the organization through its board members.

Board Governance

This department focuses on innovating and advancing scientific research to develop new products and improve existing ones.

Research and Development

This department focuses on developing and implementing machine learning algorithms and models to drive innovative solutions.

Machine Learning

This department focuses on the planning, execution, and analysis of clinical trials to support drug development and regulatory submissions.

Clinical Research

This department oversees the strategic direction and overall management of the organization.

Ataraxis AI

Org chart

Teams

Oncology Department

Board Governance

Research and Development

Machine Learning

Clinical Research

Executive Leadership

Offices

Ataraxis AI

Org chart

Teams

Oncology Department

Board Governance

Research and Development

Machine Learning

Clinical Research

Executive Leadership

Offices

Related companies